Considering the indispensable function of TMPRSS2 in the pathogenicity of SARS-CoV-2, several therapeutics that are effective in attenuating androgen receptor signaling could be repurposed for the treatment of patients with COVID-19. Here, TMPRSS2 is linked to COVID-19.